Incorporated in 2011, Dipna Pharmachem Limited is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The Company also started selling chemicals on a commission basis in the Financial year 2022. The company conducts business in Ahmedabad and the surrounding area of Ahmedabad.
The company’s product portfolio comprises 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovascular, Anti – Bacteria, Quinolones, Veterinary, Anti – Virus, Anti – Inflammatory, Neuropsychiatry, Steroid Hormone, other etc.
The company is supplying raw materials to pharmaceutical industries and the pharmaceutical industry falls under the essential business list declared by the Government.
Competitive Strengths :
- Diversified Product Portfolio
- Experienced Promoter
- Quality Service
- High level of customer satisfaction
Company Financials
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus |
|---|---|---|---|---|---|
| 31-Mar-20 | 1844.18 | 3054.85 | 5.9 | 54.75 | 51.25 |
| 31-Mar-21 | 2479.34 | 3101.54 | 2.42 | 57.17 | 53.67 |
| 31-Mar-22 | 3622.96 | 7276.58 | 116.69 | 173.86 | 170.36 |
| Amount in ₹ Lakhs |
Objects of the Issue
The company intends to utilize the Net Proceeds for the following objects :
- Working capital requirement.
- General corporate purposes.
Dipna Pharmachem IPO Details
| Dipna Pharmachem IPO Date | Aug 25, 2022 to Aug 30, 2022 |
| Dipna Pharmachem IPO Face Value | ₹10 per share |
| Dipna Pharmachem IPO Price | ₹38 per share |
| Dipna Pharmachem IPO Lot Size | 3000 Shares |
| Issue Size | 4,002,000 shares of ₹10 (aggregating up to ₹15.21 Cr) |
| Fresh Issue | 4,002,000 shares of ₹10 (aggregating up to ₹15.21 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Retail Shares Offered | 50% of the net offer |
| NII (HNI) Shares Offered | 50% of the net offer |
| Company Promoters | Mr. Keyur Dipakkumar Shah is the company promoter. |
Dipna Pharmachem IPO Lot Size
The Dipna Pharmachem IPO lot size is 3000 shares. A retail-individual investor can apply for up to 1 lots (3000 shares or ₹114,000).
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Minimum | 1 | 3000 | ₹114,000 |
| Maximum | 1 | 3000 | ₹114,000 |
Dipna Pharmachem IPO Promoter Holding
| Pre Issue Share Holding | 100% |
| Post Issue Share Holding | 66.56% |
Dipna Pharmachem IPO Review
After showing dismal performances for FY20 and FY21, it marked a bumper turnover and net profits, which appears to be a window dressing in a pre-IPO year. DPL is just a trader in pharmachem. Since it is operating in a highly competitive and fragmented segment, the sustainability of such performance is a major concern. Based on such super profits also the issue is aggressively priced. There is no harm in ignoring such a pricy bet. Read detail review…
Dipna Pharmachem IPO Prospectus
Company Contact Information
Dipna Pharmachem Limited
A/211, Siddhi Vinayak Complex,
Near D.A.V. School, Makarba,
Ahmedabad – 380 055,
Phone: +91-9898066121
Email: info@dipnapharmachem.com
Website: http://dipnapharmachem.com/
Dipna Pharmachem IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: http://www.bigshareonline.com